Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854262) titled 'EFFECT OF ESWT ON BREAST-CANCER RELATED LYMPHEDEMA' on Sept. 28.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).

Primary Sponsor: Ankara City Hospital Bilkent

Condition: Breast Cancer Related Lymphedema

Intervention: Other: Complete Decongestive Therapy

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: November 20, 2024

Target Sample Size: 48

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07854262

Published ...